Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3869_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface from the Series Editors
- •Preface from the Editors
- •Contents
- •Planning the Procedure
- •Understanding the Underlying Pathological Process
- •Understanding the Role of Alternative Therapies
- •Contributors
- •Section I
- •1 Basic Principles of Embolization
- •Introduction
- •Underlying Principles
- •Identifying the Target
- •Knowing the Arterial Anatomy and Collateral Pathways
- •Normal Anatomy and Anatomic Variations
- •Collateral Perfusion
- •End Arterial Supply
- •Choosing the Correct Embolic Material
- •Understanding the Likely Outcomes/Consequences of Embolization
- •Performing the Procedure
- •Informing Others: The Patient and Clinicians
- •Planning Vascular Access
- •Selective Catheterization
- •Single End Hole Catheters
- •Avoiding Wedged Catheter Positions
- •Microcatheters
- •Delivery of Embolic Materials
- •Preserving Vessels
- •Non-target Embolization
- •2 Coils, Occluders, and Plugs
- •Introduction
- •Mechanism of Action
- •Intimal Injury and Thrombus Formation Are Interrelated
- •Physical Properties of Embolization Coils and Plugs
- •Materials
- •Novel Materials
- •Material Issues
- •Thrombogenicity
- •Coils Shapes and Sizes
- •Coil Size
- •Terminology
- •Coil Deployment
- •Additional Techniques
- •Detachable Coils
- •Associated Complications and Strategies for Minimizing These
- •Suggested Further Reading
- •3 Permanent Particulate Agents
- •Introduction
- •Particle Physical Properties
- •Commonly Used Agents
- •Polyvinyl Alcohol Particles (PVA)
- •PVA Microspheres
- •Tris-Acryl Microspheres
- •Bio-active Particles
- •Drug-Eluting Microspheres
- •Two Types of Drug-Eluting Microspheres are Available
- •Considerations Relating to 90 Y Microspheres
- •Detectable Microspheres
- •Using Permanent Particulate Agents
- •Preparation of the Agent
- •Injection of the Agent
- •Following Injection
- •Keypoints
- •4 Temporary Embolic Agents
- •Temporary Agents
- •Autologous Blood Clot
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Detecting and Preventing Problems
- •Gelatin Sponge
- •Slurry
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It (Figure 4.1)
- •When and When Not to Use It
- •Detecting Problems
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Dosage and Side Effects
- •When to Use Absolute Alcohol
- •When Not to Use It
- •Sodium Tetradecyl Sulfate
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When to Use
- •When Not to Use It
- •N-Butyl Cyanoacrylate
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When to Use
- •When Not to Use It
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •Detecting Problems
- •Pledgets
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Detecting Problems
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use It
- •When and When Not to Use It
- •Detecting Problems
- •5 Liquid Embolic Agents
- •Sclerosing Agents
- •Physical Description and Properties
- •Mode of Action
- •How to Prepare and Use Alcohol
- •When to Use
- •When Not to Use It
- •Note
- •Lipiodol
- •Physical Description and Properties
- •Fate of Injected Lipiodol
- •Lymphatic Injection
- •Hepatic Arterial Injection
- •How to Prepare and Use It
- •When to Use
- •When Not to Use It
- •Suggested Reading
- •6 Miscellaneous Embolic Agents: Laser and Radiofrequency
- •Laser
- •About Lasers
- •Laser Power (Fig. 6.2)
- •Safety
- •Radiofrequency (Fig. 6.3)
- •Monitoring Treatment
- •Applications of Temperature-Induced Vessel Occlusion
- •Keypoints
- •7 Future Embolic Therapies
- •Gene Therapy
- •Mode of Action
- •Mechanisms of Gene Transfer/Modulation
- •Nanoparticles
- •Keypoints
- •Recommended Readings/References
- •8 Vascular Access, for Embolization: Techniques and Equipment
- •Catheter Choice
- •Catheter Properties
- •Catheter Shapes and Technical Tips
- •Reverse Curve Catheters
- •Scenarios
- •Crossing the Aortic Bifurcation
- •Technical Note: Waltman Loop Technique
- •Catheter Characteristics
- •Microcatheters
- •Advantages of Microcatheters
- •Disadvantages of Microcatheters
- •Occlusion Balloons
- •Uses of Occlusion Balloons in Embolization
- •Vascular Sheaths and Guiding Catheters
- •Guidewires
- •Support Wires
- •Exchange Wires
- •Keypoints
- •9 Pre-procedure Imaging: When, Why, and How?
- •Introduction
- •Pre-procedure Imaging: When?
- •Pre-procedure Imaging: Why?
- •Pre-procedure Imaging: How?
- •Imaging Technique
- •Contrast Enhancement
- •Clinical Scenarios
- •Thoracic Embolization
- •Hemoptysis
- •Abdominal Embolization
- •Acute Gastrointestinal Hemorrhage
- •Pre-procedure Imaging: When?
- •Pre-procedure Imaging: Why?
- •Trauma (see also Chapter 10)
- •True Aneurysms of the Visceral Arteries
- •Suggested Further Reading
- •10 Imaging the Severely Injured Patient
- •Introduction
- •Death from Trauma
- •Rationale for Early Imaging
- •Optimal Imaging
- •Image Reconstruction
- •What to Look For
- •What Next?
- •Performing Angiography
- •Considerations for Imaging Departments
- •Radiation Considerations
- •Bibliography
- •Appendix
- •11 Safety in the Periprocedural Period
- •Introduction
- •Pre-procedure
- •Procedural
- •Post-procedural
- •Safe Sedation and Analgesia During the Procedure
- •Staff
- •Equipment
- •Routine Care Equipment
- •Emergency Equipment
- •Medications
- •Complications
- •Anesthesiology Assistance During Sedation and the Use of General Anesthesia
- •Safe Sedation and Analgesia Following the Procedure
- •Contrast-Induced Nephropathy
- •Prevention of CIN
- •Patient Safety and Comfort Are Paramount
- •Suggested Readings
- •12 Complications of Embolotherapy
- •Prevention, Detection, and Recognition
- •Pre-procedure
- •During the Procedure
- •Detection and Recognition
- •During the Procedure
- •Post-procedure
- •Clinical Assessment
- •Blood Tests
- •Imaging
- •Catheters Blocking
- •Non-target Embolization
- •Coil Retrieval
- •Tissue Necrosis
- •13 Management of Post-embolization Syndrome
- •Introduction
- •Pathophysiology
- •Clinical Features
- •Pain
- •Fever
- •Nausea and Vomiting
- •Diagnostic Evaluation
- •Laboratory
- •White Cells
- •Management of PES
- •Prevention
- •Management of PES: Intraprocedural
- •Bibliography
- •Section II
- •14 Peripheral Vascular Malformations
- •Background
- •Low-Flow Lesions
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical Review
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Cautions/Contraindications
- •Anatomy
- •Medication
- •Angiography
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Follow-Up
- •High-Flow Lesions
- •Diagnostic Evaluation
- •Clinical Review
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Cautions/Contraindications
- •Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Medication
- •Angiography
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •15 Pulmonary Arteriovenous Malformations
- •Clinical Features
- •Clinical Presentation
- •Clinical Relevance
- •Clinical
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Contraindications
- •Anatomy
- •Catheters
- •Selective Catheters
- •Embolic Agents
- •Medication
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Reading
- •16 Systemic Arteriovenous Fistulae
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Anatomy
- •Equipment
- •Catheters
- •Medications
- •Pain Control
- •Infection Control
- •Sickness Control
- •Hydration
- •Arterial Access
- •Venous Access
- •Assessing the Lesion
- •Angiographic Appearance
- •Clinical Scenarios
- •Etiology of Arteriovenous Fistulae
- •Renal AVF
- •Small Post-biopsy Renal AVF
- •Congenital and Large Renal Arteriovenous Fistulae
- •Arterioportal Fistuale
- •Aortocaval Fistulae
- •Approach
- •Artery
- •Vein
- •Technical Points
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Readings
- •17 Klippel-Trenaunay Syndrome
- •Diagnosis
- •Clinical Features
- •Capillary Malformation (Fig. 17.1)
- •Hypertrophy of Bone and Soft Tissues (Fig. 17.1)
- •Venous Abnormality (Fig. 17.2)
- •Other Features
- •Assessment
- •Management
- •18 Biologic Effects of Tumor Embolization
- •Introduction
- •The Target Tissue
- •The Goal of the Embolization Procedure
- •Biological Effects on the Embolized Tissue/Organ
- •Short Term
- •Hypoxia Inducible Factor 1 (HIF-1)
- •Tumor Lysis Syndrome (TLS)
- •Target of Embolization
- •The Patient
- •The Target Organ
- •Liver
- •Kidney
- •The Disease Process
- •Recommended Reading
- •19 Liver Tumors (Hepatocellular Cancer)
- •Epidemiology of HCC
- •Diagnosis
- •Imaging
- •Differential Diagnosis Includes
- •Laboratory/Other Investigations
- •General Considerations
- •Contraindications
- •Pre-procedure Evaluation
- •Anatomic Considerations
- •Normal Anatomy
- •Variant Anatomy: (See also Table 33.1) (Fig. 19.2)
- •Extra-hepatic Supply (Fig. 19.3)
- •Consent
- •Equipment
- •Catheters
- •Chemotherapeutic Agents
- •Embolic Agent
- •Lipiodol
- •Particulate Agents
- •Drug-Eluting Beads
- •Bland Embolization Versus TACE
- •Radioembolization
- •Selective Versus Non-selective TACE
- •Procedure
- •Pre-procedure Preparation
- •Access
- •Initial Diagnostic Study
- •Selective Angiography
- •Perform Chemoembolization
- •Technique: Lipiodol
- •Technique: Drug-Eluting Beads
- •Endpoints: Two Procedural Endpoints Should be Considered
- •Post-procedure
- •Post-procedure Follow-Up
- •Assess
- •Keypoints
- •Suggested Reading
- •20 Liver Tumors: Metastases
- •Clinical Features
- •Available Embolic Therapies
- •Diagnostic Evaluation
- •Indications
- •Relative Contraindications
- •Anatomy
- •Patient Preparation
- •Pre-procedure Medications
- •Equipment
- •Post-procedure Medications
- •Follow-Up
- •Current Data
- •Alternative Therapies
- •Suggested Reading
- •21 Liver Tumors: Neuroendocrine Hepatic Metastases
- •Clinical Features
- •Laboratory
- •Imaging
- •Indications for Embolization
- •Alternative Therapies
- •Contraindications
- •Vascular Anatomy
- •Equipment
- •Catheters
- •Medications
- •IR Evaluation
- •Access
- •Arteriography
- •Assessing the Lesions
- •Angiographic Appearance
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Aftercare
- •Arterial Access Site
- •Post-embolization
- •Follow-Up
- •Suggested Reading/References
- •22 Embolization of Benign and Malignant Renal Tumors
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Indications
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Pre-operative Embolization
- •Embolization in Patients with Inoperable Cancer
- •Embolization in AML
- •Arterial Puncture Site
- •Post-embolization Syndrome
- •Follow-Up
- •Alternative Therapies
- •Keypoints
- •Safety
- •Suggested Reading
- •23 Embolization of Bone Tumors
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging (Fig. 23.1)
- •Indications
- •Alternative Therapies
- •Contraindications (Relative)
- •Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Pre-operative Embolization (Fig. 23.2)
- •Palliative Embolization
- •Embolization as a Primary Treatment
- •Complications
- •Post-embolization Syndrome
- •Follow-Up
- •24 Uterine Fibroid Embolization
- •Clinical Features
- •Diagnostic Evaluation
- •Gynecologic Examination
- •Laboratory
- •Transvaginal Ultrasound (TVUS)
- •Indications
- •Contraindications
- •Aberrant Anatomy
- •Pre-treatment Patient Information
- •Equipment
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Angiographic Appearance
- •Re-embolization of Uterine Artery
- •Arterial Puncture Site
- •Post-embolization Syndrome
- •Follow-Up
- •Treatment Failures
- •Suggested Reading
- •Appendix
- •25 Embolization of Hemorrhage Due to Pelvic Fractures
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging (see also Chapter 10)
- •Indications
- •Contraindications
- •Complications
- •Anatomy
- •Equipment
- •Catheters Required
- •Angiography (See Figs. 25.1 and 25.2)
- •Recommendations
- •Suggested Reading
- •26 Embolization of Extremity Trauma
- •Clinical Features
- •Management Goals
- •Mechanisms of Extremity Vascular Injury
- •Clinical Manifestations of Extremity Vascular Trauma
- •Role of Intervention
- •Diagnostic Evaluation
- •Clinical Evaluation
- •Physical Signs of Vascular Injury
- •Imaging
- •Radiographs
- •Indications
- •Alternative Therapies
- •Anatomy
- •Aberrant Anatomy
- •Variant Anatomy of Lower Extremity
- •Equipment
- •Catheters
- •Non-selective
- •Selective Catheters
- •Guide Catheters and Sheaths
- •Embolic Agents
- •For Dispensable Branch Vessels
- •For Indispensable Vessels
- •Medication
- •Angiography
- •Access
- •Angiographic Appearance
- •Positive Findings of Vascular Injury
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Consider
- •Special Considerations
- •Upper Limb
- •Lower Limb
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •27 Solid Organ Embolization in Trauma
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical
- •The Importance of Blood Pressure in the Context of Trauma
- •Imaging (See Also Chapter 10)
- •Abdominal Ultrasound (FAST)
- •Contrast-Enhanced CT
- •Imaging Findings: The Following Predict the Need for Intervention
- •Indications
- •Alternative Therapies
- •Surgery
- •Contraindications
- •Complications
- •Anatomy
- •Normal Anatomy and Common Variations
- •Equipment
- •Embolic Agents
- •Rarely Required
- •Medication
- •Access
- •Angiography
- •Angiographic Appearance
- •Embolization
- •Liver
- •Complications of Hepatic Embolization
- •Spleen
- •Complications of Splenic Embolization
- •Kidney
- •Complications of Renal Embolization
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Keypoints
- •28 Post-traumatic Priapism
- •Clinical Features
- •Low-Flow Priapism
- •High Flow or Arterial Priapism
- •Diagnostic Evaluation
- •Laboratory
- •Cavernosal Blood Gas Analysis
- •Imaging
- •Color Doppler Imaging of the Penis
- •Indications
- •For Angiography
- •For Embolization
- •Alternative Therapies
- •Cautions
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Medication
- •Angiography
- •Access
- •Angiography
- •Angiographic Appearance
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Safety
- •Suggested Reading
- •29 Embolization for Pancreatic Bleeding
- •Clinical Features
- •Hemorrhage in Pancreatitis
- •Hemorrhage Following Pancreatic Surgery
- •Imaging
- •Indications for Imaging and Embolization
- •Contraindications
- •Anatomy
- •Angiography and Embolization Equipment
- •Embolic Agents
- •Procedure Access
- •Angiography
- •Angiographic Appearance
- •Embolization for Post-pancreatitis Aneurysm and Pseudoaneurysm
- •Embolization for Post-operative Bleeding
- •Aftercare
- •Puncture Site
- •Post-embolization
- •Follow-Up
- •Safety
- •Bibliography
- •30 Embolization in Post-operative Hemorrhage
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Surgical Repair
- •Alternative Interventional Techniques
- •Contraindications
- •Anatomic Considerations
- •Equipment
- •Medication
- •Systemic
- •Transcatheter
- •Procedure
- •Angiographic Appearance
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Unstable Patients
- •Coagulopathic Patients
- •Active Extravasation
- •Pseudoaneurysm
- •Iatrogenic Injury During Central Line Placement
- •Post-embolization
- •Follow-Up
- •Repeat CT
- •Keypoints
- •Safety
- •Suggested Reading
- •31 Tract Embolization
- •General Concepts
- •Pre-procedure Evaluation
- •Indications for Tract Embolization
- •Contraindications
- •Material Selection
- •Operator Preference
- •Gelfoam
- •Metallic Coils
- •N-Butyl Cyanoacrylate
- •Autologous Clotted Blood/Blood Patch
- •Post-procedure Management
- •Complications
- •Results
- •Keypoints
- •References
- •32 Arterial Embolization Post-percutaneous Biopsy or Drainage
- •General Considerations
- •Bleeding Around Drains
- •Drainage Catheter Upsizing
- •Bleeding Following Biopsy
- •Risk Factors
- •Pre-procedure Evaluation
- •Patient Evaluation
- •Imaging
- •Laboratory
- •Indications for Embolization
- •Contraindications to Embolization
- •Treatment Plan and Technique
- •Pseudoaneuryms and Active Bleeding
- •Materials
- •Catheters and Microcatheters and Guidewires
- •Embolization Materials
- •Medications
- •Complications
- •Anatomy of the Lesion
- •Hematomas
- •Arteriovenous, Arterioportal, or Arteriobiliary Fistulae
- •Pseudoaneurysm
- •Bile Leaks
- •Vascular Anatomy
- •Native Liver
- •Transplanted Livers
- •Procedure/Steps
- •Embolization
- •Results
- •Complications
- •Renal Embolization Post-percutaneous Biopsy/Drainage
- •Anatomy of the Lesion
- •Hematomas
- •Arteriovenous Fistula (see Chapter 16)
- •Pseudoaneurysm
- •Vascular Anatomy
- •Native Kidneys
- •Transplanted Kidneys
- •Procedure/Steps
- •Native Kidneys
- •Transplant Kidneys
- •Results
- •Complications
- •Fatal Complication
- •Procedural Complication
- •Anatomy of the Lesion
- •Source of Bleeding
- •Imaging Findings
- •Vascular Anatomy
- •Procedure/Steps
- •Procedure Preparation
- •Angiography
- •Embolization
- •Results
- •Complications
- •Bibliography
- •33 Acute Nonvariceal Upper Gastrointestinal Hemorrhage
- •Clinical Features
- •Causes
- •Laboratory
- •Endoscopy
- •Imaging
- •Triple-Phase Multidetector Computed Tomography Angiography (CTA)
- •Indications for Embolization
- •Contraindications to Embolization
- •Anatomy
- •Embolic Agents
- •Procedure
- •Treatment Plan
- •Access
- •Angiography
- •Assessing the Lesion
- •Location
- •Gastric Bleeding
- •Duodenal Bleeding
- •Arterial Puncture Site
- •Follow-up
- •Alternative Therapies
- •Bibliography
- •34 Acute Lower Gastrointestinal (GI) Hemorrhage
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Tc-99 M RBC Study
- •Indications
- •Anatomy
- •Normal Anatomy
- •Anatomic Variation
- •Equipment
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Treatment Plan and Technique
- •Embolization
- •Follow-Up
- •Alternative Therapies
- •Suggested Reading
- •35 Bronchial Artery Embolization
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Life-Threatening Hemoptysis
- •BAE Should Also Be Considered in
- •Adjunctive and Alternative Therapies
- •Contraindications
- •All Complications Are Minimized by
- •Anatomy
- •Normal Bronchial Artery Anatomy
- •Key Points in Bronchial Arteriography
- •Aberrant/Variant Anatomy
- •Equipment
- •Catheters
- •Non-selective Catheters
- •Selective Catheters
- •Sheaths and Guide Catheters
- •Embolic Agents
- •Medication
- •Infection Control
- •Hydration
- •Angiography
- •Access and Angiography
- •Angiographic Appearance
- •Next, Identify Any Spinal Supply That
- •Embolization
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Reading
- •36 Pulmonary Hemorrhage (Non-bronchial)
- •Etiology
- •Causes of Pulmonary Arterial Hemorrhage
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Contraindications
- •Catheters
- •Embolic Agents
- •Medications
- •Procedure
- •Pulmonary Angiography
- •Assess Bleeding
- •Embolization
- •Suggested Reading
- •37 Endoleaks Following EVAR
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Catheters
- •Embolic Agents
- •Medication
- •Access
- •Angiography
- •Assessing the Lesion
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Suggested Readings
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Alternative Therapies
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Equipment
- •Catheters
- •Medication
- •Angiography
- •Access
- •Angiography
- •Assessing the Iliac Artery
- •Angiographic Appearance
- •Clinical Scenarios
- •Pre-EVAR Embolization
- •Embolization in Patients with IIAA
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Reading
- •39 Embolization of Visceral Arterial Aneurysms
- •Clinical Features
- •Natural History
- •Clinical Presentation
- •Rupture
- •Splenic Artery
- •Hepatic Artery
- •Celiac Artery
- •Superior Mesenteric Artery
- •Diagnostic Evaluation
- •Clinical
- •Laboratory
- •Imaging
- •Indications for Treatment
- •Contraindications to Treatment
- •Relevant Anatomy
- •Normal Anatomy ( ≈ 50%)
- •Aberrant Anatomy (≈ 44% with One Arterial Variant, ≈ 6% with Two Arterial Variants)
- •Equipment
- •Medication
- •Procedure
- •Alternative Therapies
- •Suggested Reading
- •40 Renal Artery Aneurysms
- •Clinical Features
- •Diagnostic Evaluation
- •Clinical
- •Laboratory
- •Imaging
- •Treatment Indications
- •Contraindications
- •Equipment
- •Procedure
- •Access
- •Angiography
- •Assessing Lesions
- •Forming a Treatment Plan
- •Covered Stent
- •Balloon Remodeling
- •Bare Stent Assisted
- •Primary Coiling
- •Performing the Embolization
- •Embolization Endpoint
- •Immediate Post-procedure Care
- •Long-Term Follow-Up
- •Results
- •Alternative Therapies
- •In Vivo Aneurysmectomy
- •Ex Vivo Resection and Autotransplant
- •Nephrectomy
- •Complications
- •Keypoints
- •Suggested Reading
- •41 Pre-operative Portal Vein Embolization
- •Pre-operative Portal Vein Embolization
- •Clinical Features
- •Laboratory
- •Imaging
- •Indications
- •Contraindications
- •Anatomy
- •Equipment
- •Catheters
- •Embolic Agents
- •Alternatives Include
- •Medications
- •Angiography
- •Access
- •Angiography
- •Embolic Agents
- •Medication
- •Angiography
- •Access
- •Angiography
- •Angiographic Appearance
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Spontaneous Epistaxis
- •Treatment Plan and Technique
- •Additional Considerations
- •Follow-Up
- •Suggested Reading
- •42 Epistaxis
- •Clinical Features
- •Diagnostic Evaluation
- •Nasal Endoscopy
- •Imaging
- •Laboratory
- •Management of Epistaxis
- •Initial Therapy
- •Indications for Embolization
- •Contraindications
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Equipment
- •Catheters
- •Hereditary Hemorrhagic Telangiectasia
- •Trauma Including Traumatic Pseudoaneurysms
- •Aftercare
- •Arterial Puncture Site
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Bibliography
- •43 Meningiomas and Paragangliomas
- •Clinical Features
- •Diagnostic Evaluation
- •Laboratory
- •Imaging
- •Indications
- •Contraindications
- •Alternative Therapies
- •Anatomy
- •Normal Anatomy
- •Aberrant Anatomy
- •Strategy
- •Equipment
- •Embolic Agents
- •Medication
- •Procedure
- •Access
- •Angiography
- •Location
- •Angiographic Appearance
- •Treatment Plan and Technique
- •Arterial Puncture Site
- •Post-embolization Syndrome
- •Follow-Up
- •Keypoints
- •Safety
- •Clinical Features
- •Diagnostic Evaluation
- •Imaging/Investigation
- •Females with Pelvic Pain
- •Males with Varicocele
- •Indications
- •Females
- •Males
- •Male Varicocele
- •Contraindications
- •General
- •Complications
- •Anatomy
- •Normal Anatomy
- •Female
- •Male
- •Aberrant Anatomy
- •Catheters
- •Embolic Agents
- •Medication
- •Venography
- •Access
- •Venography
- •Transfemoral Route
- •Angiographic Appearance
- •Ovarian Vein
- •Spermatic Vein
- •Clinical Scenarios
- •Treatment Plan and Technique
- •Ovarian Vein
- •Spermatic Vein
- •Aftercare
- •Post-embolization
- •Follow-Up
- •Keypoints
- •Safety
- •Suggested Readings
- •45 Varicose Veins
- •Clinical Features
- •Natural History of Varicose Veins
- •Diagnostic Evaluation
- •Imaging
- •Indications for Treatment
- •Surgery
- •Contraindications
- •General Complications of Venous Ablation Therapy
- •Anatomy and Physiology
- •Normal Venous Anatomy
- •Normal Lower Limb Venous Physiology
- •Equipment
- •Imaging
- •Needles
- •Guidewires
- •Catheters/Introducer Sheaths
- •Miscellaneous
- •Medication
- •Treatment Plan and Technique
- •Thermal Ablation Therapy
- •Laser Therapy
- •Laser Equipment
- •Access
- •Treatment Technique
- •Radiofrequency Ablation Therapy
- •Radiofrequency Devices
- •Technique
- •Foam Sclerotherapy
- •Clinical Scenarios
- •Varicosities
- •Foam Sclerotherapy
- •Avulsions
- •Prominent Veins in Other Sites
- •Aftercare
- •Follow-Up
- •Safety
- •Suggested Reading
- •46 Lymphatic Malformations: Sclerotherapy
- •Clinical Features and Presentation
- •Occurrence
- •Manifestations
- •Diagnostic Evaluation
- •Imaging
- •Other Cystic Lesions in the Head and Neck
- •Treatment Options
- •Evidence for Sclerotherapy
- •Anatomy
- •Equipment
- •Catheters
- •Bleomycin
- •Doxycycline
- •Medication
- •Treatment Plan and Technique
- •Children
- •Technique
- •Follow-Up
- •Safety
- •Recommended Further Reading
- •47 Thoracic Duct Embolization
- •Diagnostic Evaluation/Laboratory
- •Imaging
- •Indications
- •Medical Therapies
- •Contraindications
- •Anatomy
- •Anatomic Variation
- •Equipment
- •Embolic Agents
- •Procedure
- •Preparation
- •Pedal Lymphography
- •Access
- •Treatment Plan and Technique
- •Embolization
- •Disruption of Lymph Channels
- •Case Example (Fig. 47.2)
- •Follow-Up
- •Suggested Reading
- •48 Post-partum Hemorrhage: Embolization and Endovascular Management
- •Clinical Features
- •Diagnostic Evaluation
- •Imaging
- •Indications for Intervention/Embolization
- •Contraindications to Intervention/Embolization
- •Anatomy
- •Equipment
- •Embolic Agents
- •Procedure
- •Therapeutic Embolization for Acute PPH
- •Access
- •Angiography
- •Embolization (See Fig. 48.1)
- •Prophylactic Interventions
- •Access
- •Angiography
- •Embolization
- •Arterial Puncture Site
- •Follow-Up
- •Alternative Therapies
- •Suggested Reading
- •Index

316 G. Behrens and N.H. Patel
• Stent-graft deployment should be considered in large vessels as a method
to exclude the AVF while maintaining antegrade flow in the native
vessel.
Materials
Catheters and Microcatheters and Guidewires
• As in other chapters for the target organ—liver, kidney, lung.
Embolization Materials
• The best embolization agent to use may be the one with which you are most
familiar!
• There is usually a focal bleeding point which should be targeted as precisely
as possible whenever time allows. Proximal embolizations are generally not
warranted in this patient population.
• Coils and microcoils are often ideal; however, Gelfoam embolization can be
performed if a temporary occlusion is desired.
• In cases where speed is of the essence or the target vessel cannot be selectively
catheterized, consider proximal embolization with the following:
◦ Resorbable gelatin sponge (Gelfoam)
◦ Spherical polyvinyl alcohol particles (255 μ in size or larger) or tris-acryl
gelatin microspheres (300 μ in size or larger)
◦ N butyl cyanoacrylate and other glues
Medications
• Pain control: sedation and analgesia are recommended.
• Infection: prophylactic antibiotics are controversial.
• Hydration: intravenous normal saline.
Complications
• Fatal complications are rare.
• Major complications
◦ Non-target embolization
◦ Ischemia/tissue necrosis (usually asymptomatic)

32 Arterial Embolization Post-percutaneous Biopsy or Drainage 317
◦ Intraprocedural rupture of pseudoaneurysm; embolization needs to proceed
expeditiously
◦ Renal failure secondary to contrast-induced nephropathy
◦ Vascular dissection
• Minor complications
◦ Post-embolization syndrome
◦ Biliary stenosis due to ischemia/necrosis
◦ Groin hematoma
◦ Infection
Specific Organ Systems: Liver Embolization Post-percutaneous
Biopsy/Drainage
General Concept and Definitions
• Severe hemorrhage in the form of hemobilia, hematoma, and/or hemoperitoneum
that requires surgery or embolization is uncommon particularly when ultrasound
or CT guidance is used. The mortality of liver biopsy is 0.01–0.1%
• Bleeding occurs at the puncture sites and can result in subcapsular hematomas,
hemothorax, hemoperitoneum, arteriovenous fistulae, arterial–biliary or venous–
biliary fistulae, and arterial pseudoaneurysm.
• Ninety-six percent of such complications appear in the first 24 h and should be
suspected in any patient with falling blood pressure and rising pulse. If this is a
trend, image early.
• Percutaneous transhepatic biliary drainage (PTBD) carries a 3.7-fold higher risk
of arterial injury than other percutaneous transhepatic procedures.
Anatomy of the Lesion
Hematomas
• Post-biopsy/drainage hematomas and/or bleeding can arise from various
locations:
◦ Intraparenchymal or subcapsular: most common and usually self-limited
◦ Perihepatic or intraperitoneal
◦ Intraductal (hemobilia)
◦ Extra-abdominal (hemothorax) or at the puncture site
• Hematomas can be complex and associated with fistulae or pseudoaneurysms.
• The location of hematoma can help to identify the vessel injured.

318 G. Behrens and N.H. Patel
Arteriovenous, Arterioportal, or Arteriobiliary Fistulae
• Results from wall damage of two adjacent vascular structures or vascular
structure and bile ducts, resulting in abnormal communication.
◦ Arterioportal fistulae (see Chapter 16)
◦ Arteriovenous fistulae (see Chapter 16)
Pseudoaneurysm
• Extrahepatic
◦ Rare and potentially fatal due to severe bleeding when ruptured.
• Intrahepatic
◦ Most common type resulting from hepatic biopsy/drainage
◦ Strongly associated with fistulae and hematomas
◦ Majority of cases are asymptomatic and resolve spontaneously
Bile Leaks
• Primary bile leak after biopsy/drainage is extremely rare.
• Small bile leaks after biopsy/drainage are treated conservatively with hydration.
• Embolization is usually not required.
Specific Indications for Liver Embolization
• Severe active hemobilia on endoscopy
• Pseudoaneurysms
◦ Extrahepatic pseudoaneurysm
◦ More than 10 mm in diameter
◦ Enlarging pseudoaneurysm
• Enlarging perihepatic or subhepatic hematoma
• Arterioportal, arteriovenous, or arteriobiliary fistulae
◦ Increased portal hypertension resulting in bleeding
◦ High-flow shunt resulting in CHF, portal hypertension, or persistent GI bleed
◦ Decreased liver function
Vascular Anatomy
Native Liver
• Anatomical variants are common (see Chapter 33).
• If selective hepatic artery angiography is negative, consider other arterial sources
including diaphragmatic, intercostal, or inferior phrenic arteries.

32 Arterial Embolization Post-percutaneous Biopsy or Drainage 319
Transplanted Livers
• Review of the operative note is recommended to delineate vascular anatomy.
• Post-transplant anatomy includes the following:
◦ End-to-end anastomosis using a branch patch technique
◦ Jump graft directly from the aorta
• Gastroduodenal artery is always absent.
Procedure/Steps
• CT of the abdomen: obtain a CT in hemodynamically stable patients to rule out
intrathoracic or intra-abdominal bleeding.
Embolization
• Coils
◦ In fistulae, the aim is to embolize the actual communication or place coils in
the feeding vessel across the entire site of communication.
◦ In pseudoaneurysms, the aim is to reduce the flow into the sac to per-
mit thrombosis. Coils may be used to fill the sac or the feeding artery
is embolized both proximal and distal to the site of the pseudoaneurysm. PROXIMAL EMBOLIZATION ONLY IS INSUFFICIENT,
SINCE THIS CAN PERMIT RETROGRADE (BACKDOOR)
BLEEDING.
• Gelfoam
◦ Gelfoam slurry
◦ Gelfoam pledgets
• Permanent particulate agents are usually avoided; however, they may become
helpful to obtain distal control of a bleeding vessel that cannot be crossed with
a microcatheter for standard distal coil embolization. Injecting large particles
(>500 microns) proximal to the injured vessel will help in preventing retrograde
(backdoor) bleeding.
• Percutaneous thrombin injection
◦ There are some case reports of direct percutaneous thrombin injection into
large pseudoaneurysm under ultrasound or CT guidance.
Results
• Technical success (blockage of bleeding vessel) rates range from 95 to 100%.
• Clinical success (cessation of bleeding) around 95%.

320 G. Behrens and N.H. Patel
• Liver infarction is rare after superselective embolization, especially in a patient
with normal portal circulation.
• In cases of slow rates of bleeding, especially if venous in origin, tube upsizing
will tamponade and halt the bleeding.
Complications
• Biliary stenosis due to ischemia/necrosis.
• Worsening of liver function.
Renal Embolization Post-percutaneous Biopsy/Drainage
General Concept and Definitions
• The prevalence of vascular complications after renal biopsy/drainage has been
reported between 3 and 5%. However, the rates of major complications are around
1–2% and usually related to bleeding, arteriovenous fistula (AVF), arteriocaliceal
fistula (ACF), or pseudoaneurysm.
• Most of these complications resolve spontaneously.
• Risk of significant bleeding can be decreased with embolization of the track at
the time of the procedure or simple correction of a coagulopathic state.
• Post-biopsy vascular embolization is often considered an emergency, especially
in transplanted kidneys.
Anatomy of the Lesion
Hematomas
• Post-biopsy/drainage hematomas can occur in four anatomic spaces and are as
follows:
◦ Collecting system: resulting in hematuria, possible ureteral obstruction, and
arteriocaliceal fistula.
◦ Intrarenal or subcapsular: resulting in arteriovenous fistula, tamponade, and
pain. In severe cases, hypertension due to subcapsular hematoma compressing
the renal parenchyma (“Page kidney”) can occur.
◦ Perinephric space: hematoma formation and possibly severe hemorrhage.
“Page kidney” can also occur in this space.
◦ Pararenal/extra fascial space: resulting in large retroperitoneal or intraperi-
toneal hematoma.
• Location of hematoma can help to identify the vessel injured.
◦ Intrarenal branch

32 Arterial Embolization Post-percutaneous Biopsy or Drainage 321
◦ Main renal artery
◦ Extrarenal (e.g., lumbar artery) (see fig 32.1, 32.2 and 32.3)
Arteriovenous Fistula (see Chapter 16)
Pseudoaneurysm
• Caused by trauma to an artery, resulting in bleeding that is contained by the
adventitial layer.
• Most post-biopsy/drainage pseudoaneurysms are asymptomatic and resolve
spontaneously.
◦ Decision to treat asymptomatic pseudoaneurysms is controversial due to the
unclear and variable natural history of pseudoaneurysms. However, treatment is recommended for pseudoaneurysms larger than 10 mm or in cases
of persistent hematuria.
Specific Indications for Renal Embolization
• Renal or perirenal hematoma
◦ Severe bleeding
◦ Symtomatic bleeding
◦ Bleeding persisting for more than 72 h
• Pseudoaneurysms
◦ More than 10 mm in diameter
◦ Enlarging pseudoaneurysm
◦ Symptomatic patients
◦ Hematuria for more than 72 h
• Arteriovenous fistula
◦ Persistent AVF for more than 1 month after biopsy/drainage
◦ High-flow shunt resulting in CHF
◦ Decreased renal function
◦ Creatinine elevation
◦ Decreased GFR
• The criteria for embolization in transplant recipients remain unclear.
Vascular Anatomy
Native Kidneys
• Accessory renal arteries (polar arteries) originating from the aorta and iliac
arteries are common.

322 G. Behrens and N.H. Patel
• If selective renal artery angiogram is negative, consider other arterial sources
including lumbar, adrenal, phrenic, or mesenteric vessels.
• Ectopic kidneys and horseshoe kidneys may have very unusual arterial supplies.
Transplanted Kidneys
• Generally there is a single arterial anastomosis.
• Type of anastomosis determines angiographic approach.
Procedure/Steps
Native Kidneys
Access
• Plan according to pre-operative imaging.
• Brachial approach is recommended in patients with severe peripheral vascular
disease with aortoiliac occlusion.
Angiography
• Non-selective arteriogram
◦ Always recommended in order to identify other arterial sources of
extravasation.
◦
◦ 15
LAO aortography can be helpful to define blood supply and anatomical
variants.
• Selective arteriogram
◦ Tip of the catheter within the proximal renal artery.
• Superselective angiogram
Transplant Kidneys
Access
• Plan according to the type of anastomosis.
◦ End-to-end anastomosis: contralateral femoral approach.
◦ End-to-side anastomosis: ipsilateral femoral approach.
Angiography
• Non-selective arteriogram is recommended to exclude other arterial sources of
extravasation.
• Selective arteriogram
◦ Tip of the catheter within the proximal renal artery.

32 Arterial Embolization Post-percutaneous Biopsy or Drainage 323
◦ 20–40◦contralateral anterior oblique arteriogram with the tip of the catheter
in the proximal renal artery.
• Superselective angiogram
Angiographic Appearance
• Active bleeding: active extravasation visualized as expanding and persistent
contrast that changes morphology on delayed images.
• Pseudoaneurysm: persistent or stagnant contrast material in venous phase with
round shape (see fig 32.3).
• Arteriovenous fistula: early visualization of the renal veins.
Results
• Success rates (technical and clinical) range from 80 to 100%.
• Despite superselective embolization, renal infarctions of more than 10% of the
kidney volume are often noted.
• Infarctions of less than 30% are usually asymptomatic in native kidneys.
• Infarctions of more than 50% can be followed by renal failure, especially in
transplanted kidneys.
Complications
Fatal Complication
• Rare.
Procedural Complication
• Major complications
◦ Non-target embolization: coils can dislodge and migrate. In the case of AVF, a
small coil can travel through the fistulous communication to the lung.
◦ Ischemia/tissue necrosis: usually asymptomatic.
◦ Intraprocedural rupture of the pseudoaneurysm; embolization needs to proceed
expeditiously.
◦ Renal failure secondary to contrast-induced nephropathy.
◦ Renal artery dissection.
• Minor complications
◦ Post-embolization syndrome.
◦ Groin hematoma.
◦ There is no evidence to show that the incidence of renal hypertension increases
after superselective renal embolization.

324 G. Behrens and N.H. Patel
Lung Embolization Post-percutaneous Biopsy/Drainage
General Concept and Definitions
• The definition of massive hemoptysis varies widely in the literature, with blood
loss volumes ranging from 200 to 1000 ml per day.
• Pulmonary hemorrhage manifesting as trace hemoptysis occurs in 5–10% of
cases after lung biopsies; the vast majority are self-limited.
• Massive intraparenchymal hemorrhage requiring intervention is extremely rare
(0.01%), but the mortality rate can be as high as 75% if untreated. Death
results from massive tracheobronchial aspiration and asphyxia rather than
exanguination.
• Majority of massive bleeds arise from the bronchial circulation.
• Bleeding as a result of drainage catheter placement is classically a result of injury
to intercostal arteries rather than intraparenchymal vessels.
Anatomy of the Lesion
Source of Bleeding
• Massive intraparenchymal bleeding usually arises from the bronchial circulation
(90%).
Imaging Findings
• Tortuous bronchial vessel (especially in the setting of chronic pulmonary dis-
eases)
• Neovascularity and/or hypervascularity
• Shunting to pulmonary arterial circulation
• Active extravasation of contrast material
• Bronchial artery pseudoaneurysm
Specific Indications for Lung Embolization
• Massive hemoptysis (see Chapters 35 and 36)
• Unstable patients
◦ Requiring immediate ventilatory assistance
◦ Requiring blood transfusions
◦ Hypotensive
◦ Progressive deterioration in ventilation
• Ongoing hemorrhage despite adequate resuscitation and correction of coagulopa-
thy/thrombocytopenia

32 Arterial Embolization Post-percutaneous Biopsy or Drainage 325
Vascular Anatomy
(see Chapters 15, 35, and 36)
Procedure/Steps
Procedure Preparation
• The first step in the management of post-biopsy/drainage bleeding is to stabilize
and secure the airway!
• Chest CT scans have been reported to be superior to bronchoscopy in the
evaluation of hemoptysis by
◦ Localizing bleeding region/lobe.
◦ Defining intraparenchymal bleed versus pleural hemorrhage.
• General anesthesia may be preferred in order to protect the airway.
• Complete patient resuscitation with correction of any coagulopathy.
Angiography
• Non-selective arteriogram
◦ Always recommended to define anatomy. The tip of the flush catheter is
positioned near the left subclavian artery.
• Selective and superselective arteriogram
◦ Classic angiographic findings in patients with bronchial artery bleeding
includes the following:
• Bronchial artery enlargement (>3 mm).
• Hypervascularity.
• Parenchymal stain.
• Bronchial to pulmonary artery shunting.
• Frank extravasation is rarely seen and is not necessary to proceed with
embolization.
• After the bronchial arteries are evaluated, the potential non-bronchial systemic
collateral vessels may be interrogated.
Embolization
• Particles are the agent of choice. However, they should be used with superselective technique due to high risk of complication.
• Coils should not be used in bronchial artery embolization, because they cause
proximal occlusion and preclude re-embolization.
• Contributions from collaterals from non-bronchial arteries represent an important
cause of recurrent hemoptysis.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
